) with preserved LV systolic function and normal function of mechanical mitral valve. Coronary angiography was normal. Because of very high surgical risk (EUROSCORE 25.75, STS 20.
1
) and previous cardiac surgery the patient was referred to our Heart Team for TAVI. Under general anesthesia a self-expanding 26mm Medtronic CoreValve was successfully implanted via transfemoral approach. Because of previously implanted mechanical mitral valve the self-expanding valve was highly implanted in order to avoid collision with mechanical prosthesis. Arterial access site was successfully closed with Prostar 10 Fr closure device. Post-procedure TTE showed excellent function of self-expanding valve with peak gradient of 15 mmHg and only trace of aortic regurgitation. The patient is doing well at 6 months follow-up. A total of 6 TAVI were performed at University Hospital Center Zagreb. The patients were elderly (mean age 82.17; 76-86) and highly symptomatic with very high surgical risk (mean EUROSCORE 14.45, mean STS 19.6 2 ). Elective PCI of LMCA was performed in one patient before the procedure. All patients were implanted with self-expanding Medtronic CoreValves in general anesthesia via transfemoral approach. Artery access sites were successfully closed in all patients with Prostar closure device. In 2 of our patients permanent pacemaker has to be implanted after valve implantation. There was no in-hospital mortality and mean hospital length of stay was 10.33 days (7-13 days). One patient died 2 months after discharge because of gastro-intestinal bleeding.
KEYWORDS: aortic stenosis, mechanical mitral valve prosthesis, transcatheter aortic valve implantation.
Proπireni saaeetak / Extended abstract
Transcatheter aortic-valve implantation at the University Hospital Center Zagreb: case report and our first results
